His scientific interests lie mostly in Immunology, Antigen, T cell, Epitope and Interleukin 2. His Immunology research incorporates themes from Tissue transglutaminase, Gliadin and CD40. His Antigen study integrates concerns from other disciplines, such as Antigen presentation and Antigen-presenting cell.
His research integrates issues of Endocrinology and Internal medicine in his study of T cell. His research in Internal medicine intersects with topics in Gastroenterology and Surgery. His studies examine the connections between Epitope and genetics, as well as such issues in Molecular biology, with regards to Tyrosine phosphorylation, Intracellular, Phosphorylation, Peroxisome proliferator-activated receptor and Inflammation.
Immunology, T cell, Antigen, Internal medicine and Molecular biology are his primary areas of study. His study in Immune system, Autoimmunity, Antigen-presenting cell, Human leukocyte antigen and T lymphocyte are all subfields of Immunology. His work deals with themes such as Epitope, Epitope mapping, Cytotoxic T cell and Interleukin 2, which intersect with T cell.
As part of the same scientific family, Marco Londei usually focuses on Antigen, concentrating on Antigen presentation and intersecting with CD1 and Cell biology. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology and In vitro. The Molecular biology study combines topics in areas such as B cell, Beta, Interleukin 10 and Interleukin 4.
Marco Londei mainly investigates Immunology, Internal medicine, Immune system, IL-2 receptor and Tissue transglutaminase. His research brings together the fields of Cystic fibrosis and Immunology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
His Immune system research includes themes of In vitro, Human leukocyte antigen and Gliadin. Marco Londei combines subjects such as Oxidative stress, Inflammation, Peroxisome proliferator-activated receptor, Downregulation and upregulation and Molecular biology with his study of Tissue transglutaminase. His research in T cell intersects with topics in Epitope and Antibody.
Marco Londei mainly focuses on Immunology, Tissue transglutaminase, Downregulation and upregulation, Peroxisome proliferator-activated receptor and Inflammation. His Immunology study focuses mostly on Antigen, T cell and IL-2 receptor. His research on Antigen frequently connects to adjacent areas such as Immune system.
Marco Londei has included themes like Acquired immune system, Human leukocyte antigen, Innate immune system, Major histocompatibility complex and Interleukin 15 in his T cell study. As a part of the same scientific family, Marco Londei mostly works in the field of Tissue transglutaminase, focusing on Molecular biology and, on occasion, Oxidative stress, Tyrosine phosphorylation, Intracellular, Phosphorylation and Organ culture. His Downregulation and upregulation research incorporates themes from Proinflammatory cytokine and Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke.
Prevention of Arthritis by Interleukin 10–producing B Cells
Claudia Mauri;David Gray;Naseem Mushtaq;Marco Londei.
Journal of Experimental Medicine (2003)
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease
Luigi Maiuri;Carolina Ciacci;Ida Ricciardelli;Loredana Vacca.
The Lancet (2003)
Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells
Marco Londei;Jonathan R. Lamb;Gian Franco Bottazzo;Marc Feldmann.
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
A. P. Cope;M. Londei;N. R. Chu;S. B. A. Cohen.
Journal of Clinical Investigation (1994)
Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.
Marco Londei;Corinne M. Savill;Adrienne Verhoef;Fionula Brennan.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Interleukin 15 mediates epithelial changes in celiac disease
Luigi Maiuri;Carolina Ciacci;Salvatore Auricchio;Virginia Brown.
CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians : implications for T cell memory
Andrea Cossarizza;Claudio Ortolani;Roberto Paganelli;Daniela Barbieri.
Mechanisms of Ageing and Development (1996)
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease
Antonio Picarelli;Luigi Maiuri;Antonella Frate;Marco Greco.
The Lancet (1996)
Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.
B Grubeck-Loebenstein;G Buchan;D Chantry;H Kassal.
Clinical and Experimental Immunology (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: